Restore Balance. reclaim control.

Clinical research on umbilical cord–derived mesenchymal stem cells (hUC-MSCs) has generally found them to be well tolerated across the autoimmune conditions studied, including Crohn’s disease, rheumatoid arthritis, scleroderma and Devic disease. Because hUC-MSCs are considered immune-privileged, they carry a lower risk of immune rejection than many other cell sources. At Auragens, every plan is personalized and administered under the guidance of our medical team, with your safety and current health reviewed before, during and after treatment.

Bone marrow transplants typically use hematopoietic stem cells, often require intensive chemotherapy or radiation to “reset” the immune system first, and can carry significant risks such as graft-versus-host disease. hUC-MSC therapy uses mesenchymal stem cells sourced from the Wharton’s jelly of donated umbilical cords, collected painlessly and ethically after healthy births. These cells don’t require pre-conditioning, carry a lower risk of rejection, and work primarily by helping to modulate an overactive immune response rather than replacing the blood and immune system.

Timelines vary by condition, individual health and disease severity, and every patient responds differently. During your consultation, our medical team will walk you through realistic expectations for your specific diagnosis, based on current research.

Not necessarily. Many patients continue their current medications, including immunosuppressants or biologics. Because certain medications can influence how your body responds, our medical team will review your full medical history and current prescriptions during your consultation and provide personalized guidance. Never adjust or stop a prescribed medication without first speaking with your treating physician.

No. hUC-MSC therapy is not a cure for Crohn’s disease, rheumatoid arthritis or other autoimmune conditions. Research is ongoing into how these cells may help calm an overactive immune response and support quality of life. Our medical team will discuss realistic, clear expectations with you based on current research and your diagnosis.

Umbilical cord–derived mesenchymal stem cells (hUC-MSCs) are collected from the Wharton’s jelly of donated umbilical cords after healthy births, an ethical, non-invasive process that causes no harm to mother or baby. Compared with cells from bone marrow or adipose (fat) tissue, hUC-MSCs are younger, more abundant and less likely to trigger an immune reaction, which is why they’re a focus of autoimmune research.